Tyrosyl-CNP-22 (Human)

CAS: 142878-79-3

Ref. 3D-PCT-4251-V

Informação sobre produto

• Nome: Tyrosyl-CNP-22 (Human)
• Sinónimos: Tyr-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys Tyrosyl-C-Type Natriuretic Peptide-22, Tyr-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys, Tyrosyl-C-Type Natriuretic Peptide-22 (Human), Tyrosyl-Cnp-22 (Human), (Tyr0)-Cnp-22 (Human, Porcine, Rat), H-Tyr-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-Oh, H-Tyr-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-Oh, (Disulfide Bond)
• CAS: 142878-79-3

Descrição

Tyrosyl-CNP-22 is a peptide that binds to the C-terminal domain of the human N-methyl-D-aspartate receptor (NMDAR) and inhibits its function. It can be used as a pharmacological tool for research. Tyrosyl-CNP-22 is also an activator of the NMDAR, which may have therapeutic applications in conditions such as epilepsy. The peptide has been shown to bind specifically to the NMDAR and inhibit the function of this receptor. This inhibition can be reversed by adding excess glutamate or glycine, which are neurotransmitters that are released from neurons during synaptic transmission. Tyrosyl-CNP-22 has been shown to activate the NMDAR and promote neuronal survival in acute brain injury models, which may have therapeutic implications for conditions such as epilepsy.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 2,360.8 g/mol
• Fórmula: C₁₀₂H₁₆₆N₂₈O₃₀S₃
• Pureza: Min. 95%